Valuation: AstraZeneca PLC

Market Cap 295B 258B 238B 220B 418B 28,174B 425B 2,852B 1,118B 13,835B 1,108B 1,084B 47,923B P/E 2026 *
23.8x
P/E 2027 * 21x
Enterprise Value 314B 275B 254B 235B 446B 30,018B 453B 3,038B 1,191B 14,741B 1,181B 1,155B 51,061B EV / Sales 2026 *
4.98x
EV / Sales 2027 * 4.6x
Free-Float
96.63%
Yield 2026 *
1.75%
Yield 2027 * 1.85%

Last Transcript: AstraZeneca PLC

1 day-6.22%
1 week-3.61%
Current month-5.29%
1 month-3.20%
3 months-12.24%
6 months-5.80%
Current year-3.16%
1 week 12,388
Extreme 12388
14,566
1 month 11,484
Extreme 11484
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,178
Extreme 10178
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
May. 13Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-6.22%-3.61%+29.15%+32.09% 295B
+0.09%+0.25%+54.65%+168.55% 1,084B
-1.63%-1.50%+65.79%+62.43% 634B
-1.12%-4.27%+31.10%+85.82% 447B
+0.18%+2.04%+30.19%+26.51% 330B
-1.27%-0.56%+27.21%+46.39% 285B
-0.93%-1.19%-28.85%-40.38% 218B
-1.19%-2.81%+22.63%+61.80% 199B
-0.72%+2.72%+19.07%+78.15% 169B
+0.83%-0.29%-5.13%-32.03% 137B
Average -1.21%+2.34%+24.58%+48.93% 379.69B
Weighted average by Cap. -1.05%+2.42%+37.37%+80.15%

Financials

2026 *2027 *
Net sales 63.15B 55.25B 50.95B 47.14B 89.47B 6,028B 90.97B 610B 239B 2,960B 237B 232B 10,254B 66.78B 58.42B 53.88B 49.85B 94.61B 6,375B 96.2B 645B 253B 3,130B 251B 245B 10,843B
Net income 12.44B 10.88B 10.03B 9.28B 17.62B 1,187B 17.92B 120B 47.11B 583B 46.69B 45.68B 2,020B 13.95B 12.2B 11.25B 10.41B 19.76B 1,331B 20.09B 135B 52.82B 654B 52.36B 51.23B 2,265B
Net Debt 19.32B 16.9B 15.59B 14.42B 27.38B 1,844B 27.83B 187B 73.18B 906B 72.54B 70.97B 3,137B 11.83B 10.35B 9.54B 8.83B 16.76B 1,129B 17.04B 114B 44.8B 555B 44.41B 43.45B 1,921B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-09 GBX 13,354.00 -6.22% 6,460,021
26-07-08 GBX 14,240.00 -0.86% 1,480,149
26-07-07 GBX 14,364.00 +1.87% 1,528,247
26-07-06 GBX 14,100.00 -2.46% 2,008,204
26-07-03 GBX 14,456.00 -0.56% 653,264
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
190.30USD
Average target price
216.26USD
Spread / Average Target
+13.64%

Quarterly revenue - Rate of surprise